Vaughan Nelson Investment Management L.P. Has $69.03 Million Stake in HealthEquity, Inc. (NASDAQ:HQY)

Vaughan Nelson Investment Management L.P. increased its position in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 36.7% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 843,423 shares of the company's stock after purchasing an additional 226,563 shares during the quarter. Vaughan Nelson Investment Management L.P. owned approximately 0.97% of HealthEquity worth $69,034,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of HQY. Natixis Advisors LLC lifted its holdings in HealthEquity by 29.8% during the 3rd quarter. Natixis Advisors LLC now owns 209,175 shares of the company's stock valued at $17,122,000 after purchasing an additional 48,009 shares during the last quarter. Zions Bancorporation N.A. lifted its stake in shares of HealthEquity by 15.8% during the 3rd quarter. Zions Bancorporation N.A. now owns 20,608 shares of the company's stock worth $1,687,000 after buying an additional 2,816 shares during the last quarter. KBC Group NV boosted its holdings in shares of HealthEquity by 16.1% during the 3rd quarter. KBC Group NV now owns 2,463 shares of the company's stock worth $202,000 after buying an additional 341 shares during the period. Oppenheimer Asset Management Inc. grew its stake in HealthEquity by 7.7% in the 3rd quarter. Oppenheimer Asset Management Inc. now owns 69,139 shares of the company's stock valued at $5,659,000 after buying an additional 4,925 shares during the last quarter. Finally, Carrera Capital Advisors bought a new position in HealthEquity in the 3rd quarter valued at about $1,299,000. 99.55% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on HQY shares. BTIG Research boosted their price objective on HealthEquity from $110.00 to $130.00 and gave the stock a "buy" rating in a report on Thursday. Bank of America upped their price objective on HealthEquity from $100.00 to $120.00 and gave the company a "buy" rating in a report on Wednesday. JMP Securities reiterated a "market outperform" rating and set a $105.00 price objective on shares of HealthEquity in a research report on Wednesday, September 4th. Royal Bank of Canada reissued an "outperform" rating and issued a $92.00 target price on shares of HealthEquity in a research report on Wednesday, September 4th. Finally, Barrington Research reaffirmed an "outperform" rating and set a $105.00 price target on shares of HealthEquity in a research report on Friday, September 20th. One research analyst has rated the stock with a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $107.23.

Insider Transactions at HealthEquity

In related news, Director Frank Corvino sold 1,039 shares of the business's stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $96.10, for a total transaction of $99,847.90. Following the sale, the director now owns 3,784 shares in the company, valued at $363,642.40. The trade was a 21.54 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Robert W. Selander sold 8,250 shares of the stock in a transaction dated Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total value of $684,585.00. Following the completion of the transaction, the director now owns 54,719 shares of the company's stock, valued at $4,540,582.62. This represents a 13.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 10,536 shares of company stock valued at $884,517. 2.20% of the stock is currently owned by insiders.

HealthEquity Price Performance

Shares of NASDAQ HQY traded up $3.28 during trading hours on Friday, hitting $98.98. 1,561,907 shares of the stock were exchanged, compared to its average volume of 610,840. HealthEquity, Inc. has a 1-year low of $62.10 and a 1-year high of $101.17. The company has a market cap of $8.64 billion, a PE ratio of 82.48, a price-to-earnings-growth ratio of 1.55 and a beta of 0.52. The company has a debt-to-equity ratio of 0.51, a quick ratio of 4.10 and a current ratio of 4.10. The company's fifty day simple moving average is $85.02 and its two-hundred day simple moving average is $81.08.

HealthEquity (NASDAQ:HQY - Get Free Report) last issued its earnings results on Tuesday, September 3rd. The company reported $0.66 earnings per share for the quarter, beating analysts' consensus estimates of $0.50 by $0.16. HealthEquity had a return on equity of 9.01% and a net margin of 9.61%. The firm had revenue of $299.93 million for the quarter, compared to the consensus estimate of $284.48 million. On average, sell-side analysts predict that HealthEquity, Inc. will post 2.27 EPS for the current year.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.